Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KLHL23 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-08 |
mRNA | HTRA1 | CTRPv2 | pan-cancer | AAC | -0.21 | 1e-08 |
mRNA | RFX3 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
mRNA | RP11-159D12.5 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
mRNA | RFX7 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-08 |
mRNA | SBDS | CTRPv2 | pan-cancer | AAC | -0.21 | 1e-08 |
mRNA | SRSF3 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
mRNA | POLD1 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-08 |
mRNA | EP400 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
mRNA | ATXN7L2 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |